- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
As the global economy mends, the 2021 growth of Amyotrophic Lateral Sclerosis (ALS) Treatment will have significant change from previous year. According to our latest study, the global Amyotrophic Lateral Sclerosis (ALS) Treatment market size is USD million in 2022 from USD 293.5 million in 2021, with a change of % between 2021 and 2022. The global Amyotrophic Lateral Sclerosis (ALS) Treatment market size will reach USD 516.2 million in 2028, growing at a CAGR of 8.4% over the analysis period.
The United States Amyotrophic Lateral Sclerosis (ALS) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Amyotrophic Lateral Sclerosis (ALS) Treatment market, reaching US$ million by the year 2028. As for the Europe Amyotrophic Lateral Sclerosis (ALS) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Amyotrophic Lateral Sclerosis (ALS) Treatment players cover Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, and Apotex, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis (ALS) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Riluzole
Edaravone (Radicava)
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Drugs Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2017-2028
2.1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone (Radicava)
2.2.3 Other
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2022)
2.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2022)
3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Player
3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2020-2022)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Amyotrophic Lateral Sclerosis (ALS) Treatment by Regions
4.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2017-2022)
4.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2017-2022)
4.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2017-2022)
4.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022)
5.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
5.3 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2017-2022)
6.2 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
6.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment by Country (2017-2022)
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment by Region (2017-2022)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Regions (2023-2028)
10.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Country (2023-2028)
10.2.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Region (2023-2028)
10.3.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Country (2023-2028)
10.4.1 Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Type (2023-2028)
10.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Information
11.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Mitsubishi Tanabe Pharma Main Business Overview
11.1.5 Mitsubishi Tanabe Pharma Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Information
11.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan Pharma Main Business Overview
11.3.5 Mylan Pharma Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Information
11.5.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Glemark Generics Main Business Overview
11.5.5 Glemark Generics Latest Developments
11.6 Covis Pharma
11.6.1 Covis Pharma Company Information
11.6.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Covis Pharma Main Business Overview
11.6.5 Covis Pharma Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Information
11.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Lunan Pharma Main Business Overview
11.8.5 Lunan Pharma Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone (Radicava)
Table 4. Major Players of Other
Table 5. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2022)
Table 8. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player (2020-2022)
Table 13. Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Products Offered
Table 14. Amyotrophic Lateral Sclerosis (ALS) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 44. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 45. Key Industry Trends of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 46. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 53. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 54. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Mitsubishi Tanabe Pharma Main Business
Table 56. Mitsubishi Tanabe Pharma Latest Developments
Table 57. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 58. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Sanofi Latest Developments
Table 62. Mylan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 63. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 64. Mylan Pharma Main Business
Table 65. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Mylan Pharma Latest Developments
Table 67. Apotex Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 68. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 69. Apotex Main Business
Table 70. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Apotex Latest Developments
Table 72. Glemark Generics Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 73. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 74. Glemark Generics Main Business
Table 75. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Glemark Generics Latest Developments
Table 77. Covis Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 78. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 79. Covis Pharma Main Business
Table 80. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Covis Pharma Latest Developments
Table 82. Sun Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 83. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 84. Sun Pharma Main Business
Table 85. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sun Pharma Latest Developments
Table 87. Lunan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 88. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 89. Lunan Pharma Main Business
Table 90. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Lunan Pharma Latest Developments
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2021
Figure 7. Amyotrophic Lateral Sclerosis (ALS) Treatment in Hospital
Figure 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Amyotrophic Lateral Sclerosis (ALS) Treatment in Drugs Store
Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Drugs Store (2017-2022) & ($ Millions)
Figure 11. Amyotrophic Lateral Sclerosis (ALS) Treatment in Other
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2021
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player in 2021
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Value Market Share by Country in 2021
Figure 21. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2021
Figure 23. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2021
Figure 29. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2023-2028 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
